Tze-ChiangMengMD

PubMed

• 6 citations
  Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: Results of a phase 3, open-label extension trial.
  Tze-Chiang Meng, Jerzy P Szaflarski, Linda Chen, Marcus Brunnert, Rita Campos, Peter Van Ess, William E Pullman, Toufic Fakhoury> ;Epilepsy & Behavior. 2023 Jan 1
• 9 citations
  Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit: A double-blind, ran...
  David C. Spencer, Saurabh R. Sinha, Eun Jung Choi, Jody M. Cleveland, Aliceson King, Tze Chiang Meng, William E Pullman, David J Sequeira, Peter J. Van Ess, James W. W...> ;Epilepsia. 2020 Nov 1
• 69 citations
  Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial.
  Kamil Detyniecki, Peter J. Van Ess, David J Sequeira, James W. Wheless, Tze-Chiang Meng, William E Pullman> ;Epilepsia. 2019 May 29
• 33 citations
  Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: An open-label extension trial.
  James W. Wheless, Tze-Chiang Meng, Peter J. Van Ess, Kamil Detyniecki, David J Sequeira, William E Pullman> ;Epilepsia. 2019 Jul 29
• 37 citations
  A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic ke...
  Joseph L. Jorizzo, Orit Markowitz, Mark Lebwohl, Marc Bourcier, James H. Kulp, Tze-Chiang Meng, Sharon F. Levy> ;Journal of Drugs in Dermatology. 2010 Sep 1
• 51 citations
  Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.
  Christopher J Quirk, Kurt Gebauer, Brian De'Ambrosis, Herbert B. Slade, Tze-Chiang Meng> ;Cutis. 2010 Jun 1
• 12 citations
  Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp
  James H. Kulp, Sharon F. Levy, Melanie C. Fein, Michael Adams, John Furst, Tze-Chiang Meng> ;Archives of Dermatological Research. 2010 Mar 4
• 74 citations
  Role for Plasmacytoid Dendritic Cells in the Immune Control of Recurrent Human Herpes Simplex Virus Infection
  Heather Donaghy, Lidija Bosnjak, Andrew N. Harman, Valerie Marsden, Stephen K. Tyring, Tze-Chiang Meng, Anthony L. Cunningham> ;Journal of Virology. 2009 Feb 15
• 105 citations
  The antiviral activity of Toll-like receptor 7 and 7/8 agonists.
  Richard L. Miller, Tze-Chiang Meng, Mark A. Tomai> ;Drug News & Perspectives. 2008 Mar 1
• 85 citations
  An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
  Reinhard Dummer, Axel Hauschild, Juergen C. Becker, Jean-Jacques Grob, Dirk Schadendorf, Veronica Tebbs, Jeannine Skalsky, Katharina C. Kaehler, Stephanie Moosbauer, R...> ;Clinical Cancer Research. 2008 Feb 1
• 22 citations
  Pharmacokinetics and safety of imiquimod 5% cream in the treatment of molluscum contagiosum in children.
  Paula E. Myhre, Moise L. Levy, Lawrence F. Eichenfield, B B S Vicki Kolb, Sandra L. Fielder, Tze-Chiang Meng> ;Pediatric Dermatology. 2008 Jan 1
• 161 citations
  Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies.
  Paul J. Pockros, Dominque Guyader, Heather Patton, Myron J. Tong, Terry Wright, John G. McHutchison, Tze-Chiang Meng> ;Journal of Hepatology. 2007 Aug 1
• 27 citations
  Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
  David I. Bernstein, Spotswood L. Spruance, Sujata S. Arora, Jennifer L. Schroeder, Tze-Chiang Meng> ;Clinical Infectious Diseases. 2005 Sep 15
• 58 citations
  Randomized, Single-Blind, Placebo-Controlled Study of Topical Application of the Immune Response Modulator Resiquimod in Healthy Adults
  Daniel N. Sauder, Michael H. Smith, Therese Senta-McMillian, Inmaculada Soria, Tze-Chiang Meng> ;Antimicrobial Agents and Chemotherapy. 2003 Dec 1
• 127 citations
  Successful Treatment of Drug-Resistant Cutaneous Leishmaniasis in Humans by Use of Imiquimod, an Immunomodulator
  Iracema Arevalo, Brian J. Ward, Richard A. Miller, Tze-Chiang Meng, Enrique Najar, Eugenia Alvarez, Greg Matlashewski, Alejandro Llanos-Cuentas> ;Clinical Infectious Diseases. 2001 Dec 1
• 68 citations
  Application of a Topical Immune Response Modifier, Resiquimod Gel, to Modify the Recurrence Rate of Recurrent Genital Herpes: A Pilot Study
  Spotswood L. Spruance, Stephen K. Tyring, Michael H. Smith, Tze-Chiang Meng> ;The Journal of Infectious Diseases. 2001 Jul 15
• 28 citations
  Inhibition of Giardia lamblia excystation by antibodies against cyst walls and by wheat germ agglutinin.
  Tze-Chiang Meng, M. L. Hetsko, Frances D. Gillin> ;Infection and Immunity. 1996 Jun 1
• Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.
  Meng, T. C., Fischl, M. A., Boota, A. M., Spector, S. A., Bennett, D., Bassiakos, Y., Lai, S. H., Wright, B., Richman, D. D.> ;Ann Intern Med. 1992 Jan 1
• Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group...
  Fischl, M. A., Richman, D. D., Saag, M., Meng, T. C., Squires, K. E., Holden-Wiltse, J., Meehan, P. M.> ;J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1
• A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical...
  Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Rooney, J., Meng, T. C., Fischl, M. A., Collier, A. C., Phair, J. P., Hirsch, M. S.> ;N Engl J Med. 1995 Aug 17
• A phase II dose-ranging study of topical resiquimod to treat actinic keratosis.
  Szeimies, R. M., Bichel, J., Ortonne, J. P., Stockfleth, E., Lee, J., Meng, T. C.> ;Br J Dermatol. 2008 Jul
• Cutaneous pharmacodynamics of a toll-like receptor 7 agonist, 852A, in humans.
  Astry, C., Birmachu, W., Harrison, L. I., Meng, T. C.> ;J Clin Pharmacol. 2008 Jun
• Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions.
  Fife, K. H., Meng, T. C., Ferris, D. G., Liu, P.> ;Antimicrob Agents Chemother. 2008 Feb
• Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
  Mark, K. E., Corey, L., Meng, T. C., Magaret, A. S., Huang, M. L., Selke, S., Slade, H. B., Tyring, S. K., Warren, T., Sacks, S. L., Leone, P., Bergland, V. A., Wald, A.> ;J Infect Dis. 2007 May 1
• Join now to see all